We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Europe Exhibits New Products and Innovative Concepts in Infection Diagnostics at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 11 Apr 2022

Sysmex Europe (Norderstedt, Germany) presented new products and innovative concepts in infection diagnostics at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, which took place in Munich, Germany, from 10 to 14 April 2022. More...

In addition to presenting its latest products at the exhibition on a spacious booth, Sysmex Europe underpinned its role as a leading solution and knowledge provider by hosting three educational workshops, plus a variety of further live sessions in a dedicated presentation area.

Sysmex Europe continued supporting the event as a gold sponsor. With a two-storey booth of 128 m2 exhibition space on the ground floor and a further 40 m2 consulting area on the upper floor, Sysmex Europe showcased its competence in the fields of clinical value, workflow automation and digital services, including solutions for new business areas. In line with the brand’s key message of ‘Lighting the way with diagnostics’, Sysmex Europe has the laboratory as well as the clinician and patient in mind and looks at the bigger picture beyond the individual analyser. To strengthen its position further, the company aims at expanding its perception in new business areas while maintaining or increasing the level of trust and loyalty of their existing customers.

Visitors saw a range of new products and innovative concepts on the booth. Besides principal exhibits for the core lab areas such as hematology, haemostasis and urinalysis, and life science solutions for fecal testing, novel highlights were the XQ-320 hematology analyzer, the BloodScience Workcell, the latest clinical flow cytometry solution featuring the XF-1600, and the digital services Caresphere XQC and Sysmex Academy app. Sysmex Europe’s philosophy extends beyond the product itself, and knowing that support and continuous education is of equal importance for a rewarding user experience, the company hosted three 60-minute educational workshops within the congresses’ program, focusing on the clinical value of infection diagnostics from POC to hematology, lean workflow using Sysmex automation concept solutions, and smartening today’s laboratories by means of digital technology and services. To reach a wider audience, these on-site workshops were streamed live via Vimeo on the company’s LinkedIn channel.

Last but not least, an additional range of live lectures and ‘Meet the expert’ sessions including external speakers – in person or virtually – took place in loose succession on the company’s booth in the ‘live presentation area’ using a large, curved screen of approx. 7 x 2.5 m size. All sessions were recorded and are made available on the Sysmex Europe website, while some of these are being additionally shown via the livestream channel.

Related Links:
Sysmex Europe 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Gold Member
Latex Test
SLE-Latex Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.